France: Analysing the rules around bad faith in trade mark cases

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2025

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

France: Analysing the rules around bad faith in trade mark cases

Sponsored by

beau-de-lomenie.png

In France, a prior right holder cannot oppose a trade mark based on bad faith.

A nullity action on the basis of bad faith can be brought in court. Bad faith is a general course of action which is not specifically detailed in the French Intellectual Property Code. The rule "bad faith corrupts everything" means that one can always bring an action in court against bad faith behaviour and therefore against any trade mark filed in bad faith.

Bad faith also has an impact on prescription. The holder of a prior right may bring a nullity action against a trade mark based on relative grounds. However, the five years acquiescence rule does not apply when the trade mark was filed in bad faith. The same rule applies in cases of infringement.

In addition, the five year prescription for invalidity actions concerning well-known trade marks (Article 6bis of the Paris Convention) does not apply in cases of bad faith. As a result, when an application is filed in bad faith, the action of the prior right holder cannot be prescribed.

Article 5(4)(c) of EU Directive 2436/2015 states: "Any Member State may provide that a trade mark is not to be registered, or, if registered, is liable to be declared invalid where, and to the extent that the trade mark is liable to be confused with an earlier trade mark protected abroad, provided that, at the date of the application, the applicant was acting in bad faith." This Directive must be implemented in France no later than January 14 2019.

There is no information for the moment as to whether an action will be introduced in France. However, if bad faith can be proved in French territory, there is a ground for action in court. Finally, there is, up to now, no information about how nullity actions filed before the Office will be dealt with in France.

Aurélia Marie


Cabinet Beau de Loménie

158, rue de l’Université

F - 75340 Paris Cedex 07 France

Tel: +33 1 44 18 89 00

Fax: +33 1 44 18 04 23

contact@bdl-ip.com

www.bdl-ip.com

more from across site and SHARED ros bottom lb

More from across our site

Licensing chief Patrik Hammarén also reveals that the company will rename its IPR business to better reflect its role in defining standards
The acquisition of Pecher & Partners follows the firm’s earlier expansion into litigation to create a ‘one-stop shop’
News of Via Licensing Alliance launching its first semiconductor patent pool and INTA electing a new president were also among the top talking points
Submit your nominations to this year's WIBL Americas Awards by January 23
The 2026 Life Sciences EMEA Awards is now open for entries. We are looking forward to reviewing and celebrating the industry's most impressive achievements and landmarks from the past year.
The tie-up between Perkins Coie and Ashurst may generate some striking numbers, but independent IP firms need not worry yet, according to practitioners
Perkins Coie’s US patent prosecution strength could provide Ashurst with an opportunity to enter an untapped market in Australia, but it may not be easy
Mitesh Patel at Reed Smith outlines why the US Copyright Office and courts have so far dismissed AI authorship and how inventors can protect AI-generated works
Xia Zheng, founder of AFD China, discusses balancing legal work with BD, new approaches to complex challenges, and the dangers of ‘over-optimism’
A dispute involving semiconductor technology and a partner's move from Hoffman Eitle to Hoyng Rokh Monegier were also among the top talking points
Gift this article